Table 1.
Baseline Characteristics of Cohort of All Participants Enrolled in Study
| Participant Characteristics at Baseline (N=557) | N or Median (% or IQR) |
|---|---|
| Study Site | |
| San Francisco | 300 (53.9%) |
| Miami | 157 (28.2%) |
| Washington, DC | 100 (18.0%) |
|
| |
| Age (years) | |
| 18–29 | 205 (36.8%) |
| 30–39 | 181 (32.5%) |
| 40+ | 171 (30.7%) |
|
| |
| Gender | |
| Male | 548 (98.4%) |
| Transgender women | 7 (1.3%) |
| Other | 2 (0.4%) |
|
| |
| Race/ethnicity | |
| White | 266 (47.8%) |
| Latino | 192 (34.5%) |
| Black/African-American | 40 (7.2%) |
| Asian | 26 (4.7%) |
| Other | 32 (5.8%) |
|
| |
| Hypertension | |
| No | 494 (88.7%) |
| Yes | 63 (11.3%) |
|
| |
| Diabetes mellitus | |
| No | 548 (98.4%) |
| Yes | 9 (1.6%) |
|
| |
| Anti-hypertensive or diabetic medication use | |
| No | 520 (93.4%) |
| Yes | 37 (6.6%) |
|
| |
| Recreational drug use | |
| No | 133 (26.7%) |
| Yes | 366 (73.4%) |
|
| |
| Nonsteroidal anti-inflammatory drug use | |
| No | 480 (86.2%) |
| Yes | 77 (13.8%) |
|
| |
| Weight (kg) | 76 (70–88) |
|
| |
| Baseline serum creatinine (mg/dL) | 0.92 (0.83–1.01) |
| Baseline CrCl (mL/min) | 124 (108–144) |
| ≥90 | 504 (91.5%) |
| ≥70 to <90 | 47 (8.5%) |
| Baseline eGFR (mL/min/1.73m2) | 108 (96–119) |
| ≥90 | 463 (83.1%) |
| ≥70 to <90 | 85 (15.3%) |
| ≥60 to <70 | 7 (1.3%) |
| <60 | 2 (0.4%) |
CrCl = creatinine clearance, calculated using the Cockcroft-Gault equation; eGFR = estimated glomerular filtration rate calculated by the Chronic Kidney Disease Epidemiology Collaboration equation.